Overweight and obesity as risk factors for COVID-19-associated hospitalisations and death: systematic review and meta-analysis.

IF 3.3 Q2 NUTRITION & DIETETICS
BMJ Nutrition, Prevention and Health Pub Date : 2022-01-19 eCollection Date: 2022-01-01 DOI:10.1136/bmjnph-2021-000375
Wendemi Sawadogo, Medhin Tsegaye, Andinet Gizaw, Tilahun Adera
{"title":"Overweight and obesity as risk factors for COVID-19-associated hospitalisations and death: systematic review and meta-analysis.","authors":"Wendemi Sawadogo,&nbsp;Medhin Tsegaye,&nbsp;Andinet Gizaw,&nbsp;Tilahun Adera","doi":"10.1136/bmjnph-2021-000375","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To quantify the current weight of evidence of the association between overweight and obesity as risk factors for COVID-19-related hospitalisations (including hospital admission, intensive care unit admission, invasive mechanical ventilation) and death, and to assess the magnitude of the association and the potential dose-response relationships.</p><p><strong>Design: </strong>PubMed, Embase, Cochrane, Web of Sciences, WHO COVID-19 database and Google Scholar were used to identify articles published up to 20 July 2021. Peer-reviewed studies reporting adjusted estimates of the association between overweight or obesity and COVID-19 outcomes were included. Three authors reviewed the articles and agreed. The quality of eligible studies was assessed using the Newcastle-Ottawa Quality Assessment Scale. Random-effects meta-analysis was used to estimate the combined effects.</p><p><strong>Results: </strong>A total of 208 studies with 3 550 997 participants from over 32 countries were included in this meta-analysis. Being overweight was associated with an increased risk of COVID-19-related hospitalisations (OR 1.19, 95% CI 1.12 to 1.28, n=21 studies), but not death (OR 1.02, 95% CI 0.92 to 1.13, n=21). However, patients with obesity were at increased risk of both COVID-19-related hospitalisations (OR 1.72, 95% CI 1.62 to 1.84, n=58) and death (OR 1.25, 95% CI 1.19 to 1.32, n=77). Similarly, patients with extreme obesity were at increased risk of COVID-19-related hospitalisations (OR 2.53, 95% CI 1.67 to 3.84, n=12) and death (OR 2.06, 95% CI 1.76 to 3.00, n=19). There was a linear dose-response relationship between these obesity categories and COVID-19 outcomes, but the strength of the association has decreased over time.</p><p><strong>Conclusion: </strong>Being overweight increases the risk of COVID-19-related hospitalisations but not death, while obesity and extreme obesity increase the risk of both COVID-19-related hospitalisations and death. These findings suggest that prompt access to COVID-19 care, prioritisation for COVID-19 vaccination and other preventive measures are warranted for this vulnerable group.</p>","PeriodicalId":36307,"journal":{"name":"BMJ Nutrition, Prevention and Health","volume":null,"pages":null},"PeriodicalIF":3.3000,"publicationDate":"2022-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/20/4e/bmjnph-2021-000375.PMC8783972.pdf","citationCount":"48","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMJ Nutrition, Prevention and Health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/bmjnph-2021-000375","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"NUTRITION & DIETETICS","Score":null,"Total":0}
引用次数: 48

Abstract

Objective: To quantify the current weight of evidence of the association between overweight and obesity as risk factors for COVID-19-related hospitalisations (including hospital admission, intensive care unit admission, invasive mechanical ventilation) and death, and to assess the magnitude of the association and the potential dose-response relationships.

Design: PubMed, Embase, Cochrane, Web of Sciences, WHO COVID-19 database and Google Scholar were used to identify articles published up to 20 July 2021. Peer-reviewed studies reporting adjusted estimates of the association between overweight or obesity and COVID-19 outcomes were included. Three authors reviewed the articles and agreed. The quality of eligible studies was assessed using the Newcastle-Ottawa Quality Assessment Scale. Random-effects meta-analysis was used to estimate the combined effects.

Results: A total of 208 studies with 3 550 997 participants from over 32 countries were included in this meta-analysis. Being overweight was associated with an increased risk of COVID-19-related hospitalisations (OR 1.19, 95% CI 1.12 to 1.28, n=21 studies), but not death (OR 1.02, 95% CI 0.92 to 1.13, n=21). However, patients with obesity were at increased risk of both COVID-19-related hospitalisations (OR 1.72, 95% CI 1.62 to 1.84, n=58) and death (OR 1.25, 95% CI 1.19 to 1.32, n=77). Similarly, patients with extreme obesity were at increased risk of COVID-19-related hospitalisations (OR 2.53, 95% CI 1.67 to 3.84, n=12) and death (OR 2.06, 95% CI 1.76 to 3.00, n=19). There was a linear dose-response relationship between these obesity categories and COVID-19 outcomes, but the strength of the association has decreased over time.

Conclusion: Being overweight increases the risk of COVID-19-related hospitalisations but not death, while obesity and extreme obesity increase the risk of both COVID-19-related hospitalisations and death. These findings suggest that prompt access to COVID-19 care, prioritisation for COVID-19 vaccination and other preventive measures are warranted for this vulnerable group.

Abstract Image

Abstract Image

超重和肥胖是与covid -19相关的住院和死亡的危险因素:系统回顾和荟萃分析
目的:量化超重和肥胖作为covid -19相关住院(包括住院、重症监护病房住院、有创机械通气)和死亡危险因素之间关联的证据的当前权重,并评估这种关联的程度和潜在的剂量-反应关系。设计:使用PubMed、Embase、Cochrane、Web of Sciences、WHO COVID-19数据库和Google Scholar来识别截至2021年7月20日发表的文章。纳入了报告超重或肥胖与COVID-19结局之间关系的经同行评审的研究。三位作者审阅了这些文章并表示同意。使用纽卡斯尔-渥太华质量评估量表评估符合条件的研究的质量。随机效应荟萃分析用于估计综合效应。结果:本荟萃分析共纳入了来自32个国家的208项研究,涉及3 550 997名受试者。超重与covid -19相关住院的风险增加相关(OR 1.19, 95% CI 1.12至1.28,n=21项研究),但与死亡无关(OR 1.02, 95% CI 0.92至1.13,n=21)。然而,肥胖患者与covid -19相关的住院治疗(OR 1.72, 95% CI 1.62至1.84,n=58)和死亡(OR 1.25, 95% CI 1.19至1.32,n=77)的风险都增加了。同样,极度肥胖的患者与covid -19相关的住院治疗(OR 2.53, 95% CI 1.67至3.84,n=12)和死亡(OR 2.06, 95% CI 1.76至3.00,n=19)的风险增加。这些肥胖类别与COVID-19结局之间存在线性剂量反应关系,但这种关联的强度随着时间的推移而减弱。结论:超重会增加与covid -19相关的住院风险,但不会增加死亡风险,而肥胖和极度肥胖会增加与covid -19相关的住院和死亡风险。这些发现表明,有必要为这一弱势群体及时提供COVID-19护理,优先接种COVID-19疫苗并采取其他预防措施。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
BMJ Nutrition, Prevention and Health
BMJ Nutrition, Prevention and Health Nursing-Nutrition and Dietetics
CiteScore
5.80
自引率
0.00%
发文量
34
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信